Back to BlackRock Finance, Inc. BlackRock Finance, Inc.

LYELLYEL
Showing 1 of 3 quarters

Position history for BlackRock Finance, Inc.BlackRock Finance, Inc.'s holdings in LYELL IMMUNOPHARMA INC

BlackRock Finance, Inc. holds 13.5M shares of LYEL (LYELL IMMUNOPHARMA INC), worth $19.6M as of 2024-Q2. The position was decreased (-2.9% shares). LYEL represents 0.0% of BlackRock Finance, Inc.'s portfolio.

Current Value

$19.6M

Current Shares

13.5M

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Decreased
13.5M
-2.9%
$19.6M0.0%$29.00
0

Other major holders of LYEL: HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC

Upgrade to Pro to see multi-quarter position history and trends. View plans

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used